Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reduction in IV Associated Contamination

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01426217
Recruitment Status : Completed
First Posted : August 31, 2011
Results First Posted : October 18, 2018
Last Update Posted : October 18, 2018
Sponsor:
Collaborator:
PSI Medical
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center

Brief Summary:
The purpose of this study is to investigate whether implementing a novel syringe and IV stopcock cap system impregnated with alcohol will reduce IV catheter bacterial contamination and infections in patients.

Condition or disease Intervention/treatment Phase
Post-operative Infections Device: Passive Bundle PSI (Problem Solving Innovations) Medical HubScrub, PSI Medical DocIt Not Applicable

Detailed Description:
Bacterial contamination of patient intravenous stopcock sets is a common intraoperative event associated with increased patient mortality, possibly via an infectious mechanism. The most common type of intravenous tubing used in operating rooms is the open lumen stopcock set which lacks a barrier between the environment and intraluminal space, and thus the intravascular space of the patient. The stopcock connector can be easily contaminated by provider hands due to improper handling of the device and/or contaminated by soiled syringe tips subsequently connected to the device. Further, the stopcock connector is often left uncapped by the provider and directly exposed to the environment. Thus, common breaches in intraoperative aseptic practice of healthcare providers can lead to bacterial contamination of the endoluminal space of the open lumen device. The primary aim of the current study is to assess the efficacy of a passive bundle designed to decrease intravenous stopcock and tubing intraluminal bacterial contamination. This passive bundle includes two novel interventions, a DOCit station and HubScrub caps. The HubScrub is designed to clean the needleless connectors and open lumen stopcock systems. The DOCit station is designed to simultaneously clean the interior and exterior of needle-less luer connectors of syringes with isopropyl alcohol while also providing a method of storage and organization of multiple syringes. The investigators hypothesize that the application of this passive bundle to the standard open lumen system commonly employed by anesthesia providers in the operating room will significantly reduce bacterial contamination of standard 3-way open lumen stopcock sets and improve patient safety.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 594 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Prevention
Official Title: Reduction in Intraoperative Lumen Contamination of Standard 3-Way Open Lumen Stopcock Sets Through Use of a Novel, Passive Bundle
Study Start Date : August 2011
Actual Primary Completion Date : November 2011
Actual Study Completion Date : November 2011

Arm Intervention/treatment
No Intervention: Control
Control arm using standard of care operating room procedures and equipment
Experimental: Problem Solving Innovations (PSI) Experimental
Implementation of the passive bundle including HubScrub and DocIt
Device: Passive Bundle PSI (Problem Solving Innovations) Medical HubScrub, PSI Medical DocIt
Implementation of passive bundle which includes HubScrub and DocIt device into the operating room environment.
Other Names:
  • PSI Medical HubScrub
  • PSI Medical DocIt




Primary Outcome Measures :
  1. Presence of Bacterial IV Stopcock Lumen Contamination [ Time Frame: 48 hours ]
    The presence of bacteria in the stopcock lumen was assessed by analyzing swab cultures of the lumens. Each swab potentially containing bacteria from any of the 3 lumens of the stopcock sets were analyzed


Secondary Outcome Measures :
  1. Presence of Positive Bacterial Culture in IV Stopcock Due to Effluent Contamination [ Time Frame: Until positive, up to 5 days ]
    Open lumen ports were removed from the patient; sent directly to the anesthesiology microbiology laboratory; connected by the same clinical laboratory scientist to sterile catheters using sterile, aseptic technique; and injected directly into a BacT/Alert 3D system (bioMérieux Inc., Durham, NC) with 2 mL of sterile saline per port. BacT/Alert is a blood culture system that automatically monitors bacterial growth using colorimetry; a sensor inserted at the bottom of the bottle changes color on detecting the carbon dioxide produced by the growth of the bacteria. Catheters were then removed, and the bottles were directly incubated in the BacT/Alert system for 5 days or until positive. Once positive, the liquid in the bottle was examined to identify the organism.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Adult patient undergoing surgery or procedure in operating room
  • Undergoing general anesthesia

Exclusion Criteria:

  • Children (age < 18 years)
  • Lack of intravenous access
  • failure of anesthesia provider to complete training on experimental device

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01426217


Locations
Layout table for location information
United States, New Hampshire
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756
Sponsors and Collaborators
Dartmouth-Hitchcock Medical Center
PSI Medical
Investigators
Layout table for investigator information
Principal Investigator: Bryan S Brindeiro, MD Dartmouth-Hitchcock Medical Center
Study Director: Randy W Loftus, MD Dartmouth-Hitchcock Medical Center
Publications of Results:
Other Publications:
Layout table for additonal information
Responsible Party: Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier: NCT01426217    
Other Study ID Numbers: 22743
First Posted: August 31, 2011    Key Record Dates
Results First Posted: October 18, 2018
Last Update Posted: October 18, 2018
Last Verified: August 2018
Keywords provided by Dartmouth-Hitchcock Medical Center:
IV contamination
intravenous contamination
stopcock contamination
surgical site infection
Additional relevant MeSH terms:
Layout table for MeSH terms
Infections